Catalent - CTLT Stock Forecast, Price & News

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Catalent in the last twelve months. There are currently 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CTLT shares.
View CTLT analyst ratings or view top-rated stocks.

8 analysts have issued 1 year price objectives for Catalent's shares. Their CTLT share price forecasts range from $60.00 to $145.00. On average, they predict the company's stock price to reach $92.80 in the next twelve months. This suggests a possible upside of 77.7% from the stock's current price.
View analysts price targets for CTLT or view top-rated stocks among Wall Street analysts.

Catalent's stock was trading at $128.03 at the start of the year. Since then, CTLT shares have decreased by 59.2% and is now trading at $52.23.
View the best growth stocks for 2022 here.

Catalent saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 3,580,000 shares, a drop of 11.8% from the October 31st total of 4,060,000 shares. Based on an average daily trading volume, of 2,390,000 shares, the short-interest ratio is currently 1.5 days.
View Catalent's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 7th 2023.
View our CTLT earnings forecast.

Catalent, Inc. (NYSE:CTLT) posted its quarterly earnings data on Tuesday, November, 1st. The company reported $0.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.49 by $0.24. The company earned $1.02 billion during the quarter, compared to analysts' expectations of $1.06 billion. Catalent had a net margin of 8.83% and a trailing twelve-month return on equity of 12.55%.
Read the conference call transcript.

Catalent issued an update on its FY 2023 earnings guidance on Tuesday, November, 8th. The company provided EPS guidance of $3.13-$3.54 for the period, compared to the consensus EPS estimate of $3.76. The company issued revenue guidance of $4.63 billion-$4.88 billion, compared to the consensus revenue estimate of $5.08 billion.

391 employees have rated Catalent Chief Executive Officer John R. Chiminski on Glassdoor.com. John R. Chiminski has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Catalent investors own include Abbott Laboratories (ABT), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), NVIDIA (NVDA), Alibaba Group (BABA), Bristol-Myers Squibb (BMY), AT&T (T) and Cisco Systems (CSCO).

Catalent trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTLT."

Catalent's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (10.68%), BlackRock Inc. (8.94%), State Street Corp (3.96%), Veritas Asset Management LLP (3.87%), Artisan Partners Limited Partnership (3.26%) and Price T Rowe Associates Inc. MD (1.07%). Insiders that own company stock include Alessandro Maselli, Aristippos Gennadios, Associates LP Ta, Gregory T Lucier, Gregory T Lucier, John R Chiminski, John R Chiminski, Jonathan Arnold, Karen Flynn, Kay A Schmidt, Kay A Schmidt, Mario Gargiulo, Michael A Riley, Michael J Grippo, Michael J Grippo, Peter Zippelius, Ricardo Pravda, Ricci S Whitlow, Ricci S Whitlow, Ricky Hopson, Scott Gunther, Steven L Fasman, Steven L Fasman, Thomas P Castellano, Thomas W Hawkeswood and Wetteny Joseph.
View institutional ownership trends.

Shares of CTLT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CTLT stock can currently be purchased for approximately $52.23.

Catalent (NYSE:CTLT) has a market capitalization of $9.40 billion and generates $4.83 billion in revenue each year. The company earns $503 million in net income (profit) each year or $2.34 on an earnings per share basis.

The company employs 19,000 workers across the globe.

Catalent's mailing address is 14 SCHOOLHOUSE ROAD, SOMERSET NJ, 08873. The official website for the company is www.catalent.com. The company can be reached via phone at (732) 537-6200, via email at investors@catalent.com, or via fax at 732-537-6480.